These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22963556)

  • 1. Antiviral drugs in the prophylaxis of HBV infection.
    Masgala A; Nikolopoulos G; Tsiodras S; Bonovas S; Sitaras NM
    Curr Med Chem; 2012; 19(35):5940-6. PubMed ID: 22963556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
    Yağci M; Acar K; Sucak GT; Aki Z; Bozdayi G; Haznedar R
    Leuk Lymphoma; 2006 Aug; 47(8):1608-12. PubMed ID: 16966273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The difficulties of managing severe hepatitis B virus reactivation.
    Roche B; Samuel D
    Liver Int; 2011 Jan; 31 Suppl 1():104-10. PubMed ID: 21205146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.
    Cholongitas E; Papatheodoridis GV
    World J Gastroenterol; 2013 Dec; 19(48):9189-97. PubMed ID: 24409047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy.
    Idilman R
    J Antimicrob Chemother; 2005 Jun; 55(6):828-31. PubMed ID: 15849263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
    Kohrt HE; Ouyang DL; Keeffe EB
    Clin Liver Dis; 2007 Nov; 11(4):965-91, x. PubMed ID: 17981237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
    Law MF; Ho R; Cheung CK; Tam LH; Ma K; So KC; Ip B; So J; Lai J; Ng J; Tam TH
    World J Gastroenterol; 2016 Jul; 22(28):6484-500. PubMed ID: 27605883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatitis B in liver transplant recipients.
    Coffin CS; Terrault NA
    J Viral Hepat; 2007 Nov; 14 Suppl 1():37-44. PubMed ID: 17958641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy.
    Francisci D; Falcinelli F; Schiaroli E; Capponi M; Belfiori B; Flenghi L; Baldelli F
    Infection; 2010 Feb; 38(1):58-61. PubMed ID: 19904491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in prevention of hepatitis B recurrence after liver transplantation.
    Xi ZF; Xia Q
    World J Gastroenterol; 2015 Jan; 21(3):829-35. PubMed ID: 25624716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy.
    Rossi G
    Leuk Lymphoma; 2003 May; 44(5):759-66. PubMed ID: 12802911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
    Fan LY; Zhou Z; Zhong S; Ling N; Wang ZY; Shi XF; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):429-33. PubMed ID: 19567021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment induced seroconversion to HBsAb following HBV reactivation in the immunosuppressed haematology and oncology patient: a clinical survey of 5 cases in Catania, Italy.
    Montineri A; Nigro L; La Rosa R; Iacobello C; Larocca L; Cappello E; Fiumara PF; Di Raimondo F; Fatuzzo F
    J Clin Virol; 2011 Dec; 52(4):284-7. PubMed ID: 21906994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.
    Hui CK; Cheung WW; Au WY; Lie AK; Zhang HY; Yueng YH; Wong BC; Leung N; Kwong YL; Liang R; Lau GK
    Gut; 2005 Nov; 54(11):1597-603. PubMed ID: 16000641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy.
    Chen WC; Cheng JS; Chiang PH; Tsay FW; Chan HH; Chang HW; Yu HC; Tsai WL; Lai KH; Hsu PI
    PLoS One; 2015; 10(6):e0131545. PubMed ID: 26121480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamivudine facilitates optimal chemotherapy in hepatitis B virus-infected children with hematological malignancies: a preliminary report.
    el-Sayed MH; Shanab G; Karim AM; el-Tawil A; Black A; Dixon JS
    Pediatr Hematol Oncol; 2004 Mar; 21(2):145-56. PubMed ID: 15160513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies.
    Yağci M; Ozkurt ZN; Yeğin ZA; Aki Z; Sucak GT; Haznedar R
    Hematology; 2010 Aug; 15(4):240-4. PubMed ID: 20670484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult HBV infection in the oncohematological setting.
    Sagnelli C; Macera M; Pisaturo M; Zampino R; Coppola M; Sagnelli E
    Infection; 2016 Oct; 44(5):575-82. PubMed ID: 27076347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.